Arch Pharmalabs is looking for European acquisitions following the opening of its new manufacturing facility in Gurgaon, India. The new $12.5m facility, which will manufacture APIs for the US and European markets, includes four manufacturing plants and a pilot plant. Arch expects the facility to be inspected by the US FDA in the first half of 2008. Ajit Kamath, Arch's managing director,, said the company is also looking to acquiring a medium sized firm in Europe with sales of $100m.
Business Standard
Tuesday 26 February 2008
Arch looks to Europe
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment